SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-19-234332
Filing Date
2019-08-30
Accepted
2019-08-29 20:24:46
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 d751823ds3.htm S-3 457939
2 EX-1.2 d751823dex12.htm EX-1.2 210055
3 EX-4.10 d751823dex410.htm EX-4.10 364863
4 EX-4.11 d751823dex411.htm EX-4.11 368099
5 EX-5.1 d751823dex51.htm EX-5.1 42346
6 EX-23.1 d751823dex231.htm EX-23.1 1809
7 GRAPHIC g751823g73u99.jpg GRAPHIC 38276
8 GRAPHIC g751823stamp73.jpg GRAPHIC 3343
9 GRAPHIC g751823stamp74.jpg GRAPHIC 1837
  Complete submission text file 0001193125-19-234332.txt   1506366
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-233537 | Film No.: 191067664
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences